Back to 
TWO SIGMA INVESTMENTS, LP
TWO SIGMA INVESTMENTS, LP
PTGXShowing 4 of 27 quarters
Position history for TWO SIGMA INVESTMENTS, LP's holdings in PROTAGONIST THERAPEUTICS INC
No. Two Sigma exited its PTGX (Protagonist Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 5,741 shares worth $277,635. Two Sigma already held PTGX in its Q4 2018 13F, the earliest on record, and held it in 26 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$256,995
Total Shares Change
-5,711
Quarter-by-Quarter History
Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.